Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMNB
3576
DELISTED
American National Bankshares Inc
AMNB
| $63.6K | ﹤0.01% |
2,194
-3,037
| -58% | -$87.3K |
|
|
QVCGA
3577
DELISTED
QVC Group Inc Series A
QVCGA
| $63.4K | ﹤0.01% |
1,281
-15,213
| -92% | -$685K |
|
|
KLRS
3578
Kalaris Therapeutics
KLRS
$83.5M
| $63.1K | ﹤0.01% |
807
-742
| -48% | -$70.5K |
|
|
SRG
3579
Seritage Growth Properties
SRG
$136M
| $63K | ﹤0.01% |
+7,060
| New | +$56.4K |
|
|
ZIMV
3580
DELISTED
ZimVie
ZIMV
| $62.7K | ﹤0.01% |
5,586
-5,411
| -49% | -$52.5K |
|
|
SCNX
3581
Scienture Holdings
SCNX
$15.5M
| $62.7K | ﹤0.01% |
+4,801
| New | +$26.9K |
|
3582
Evolution Petroleum
EPM
$132M
| $62.5K | ﹤0.01% |
7,745
-26,871
| -78% | -$199K |
|
|
TEI
3583
Templeton Emerging Markets Income Fund
TEI
$314M
| $62.5K | ﹤0.01% |
10,902
+98
| +0.9% | +$495 |
|
|
GHIXW
3584
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
| $61.9K | ﹤0.01% |
458,333
| – | – |
|
3585
KraneShares Electric Vehicles and Future Mobility Index ETF
KARS
$76.9M
| $61.8K | ﹤0.01% |
1,980
| – | – |
|
3586
Star Holdings Shares of Beneficial Interest
STHO
$113M
| $61.7K | ﹤0.01% |
4,208
-2,923
| -41% | -$46.3K |
|
|
ARIS
3587
DELISTED
Aris Water Solutions
ARIS
| $61.5K | ﹤0.01% |
5,956
-5,152
| -46% | -$44.5K |
|
3588
Puma Biotechnology
PBYI
$404M
| $61.2K | ﹤0.01% |
17,340
+42
| +0.2% | +$131 |
|
3589
Waterstone Financial
WSBF
$370M
| $60.7K | ﹤0.01% |
4,191
-5,370
| -56% | -$76.7K |
|
3590
Hagerty
HGTY
$1.17B
| $60.6K | ﹤0.01% |
6,474
+4,494
| +227% | +$41.4K |
|
|
PLM
3591
DELISTED
PolyMet Mining Corp.
PLM
| $60.5K | ﹤0.01% |
76,526
-17,925
| -19% | -$26.9K |
|
3592
Oric Pharmaceuticals
ORIC
$1.15B
| $60.3K | ﹤0.01% |
+7,772
| New | +$44.1K |
|
3593
AlTi Global
ALTI
$399M
| $60.2K | ﹤0.01% |
7,864
-1,380
| -15% | -$9.67K |
|
3594
Vuzix
VUZI
$194M
| $59.8K | ﹤0.01% |
11,723
-18,223
| -61% | -$80.7K |
|
|
GPMT
3595
Granite Point Mortgage Trust
GPMT
$69M
| $59.5K | ﹤0.01% |
11,231
-19,443
| -63% | -$92.3K |
|
|
NETI
3596
DELISTED
Eneti Inc.
NETI
| $59.4K | ﹤0.01% |
4,909
-6,287
| -56% | -$61.3K |
|
3597
NWPX Infrastructure Inc
NWPX
$1.19B
| $59.4K | ﹤0.01% |
1,965
-3,970
| -67% | -$113K |
|
3598
Citizens & Northern Corp
CZNC
$456M
| $59.3K | ﹤0.01% |
3,074
-4,540
| -60% | -$89K |
|
3599
West Bancorporation
WTBA
$478M
| $59.1K | ﹤0.01% |
3,213
-4,969
| -61% | -$86.6K |
|
3600
Greenlight Captial
GLRE
$552M
| $59.1K | ﹤0.01% |
5,611
-7,662
| -58% | -$75.8K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.